Acadia Healthcare Company Inc. (NASDAQ:ACHC) has recently been highlighted as one of the cheap US stocks to buy according to analysts. KeyBanc recently adjusted the price target for Acadia Healthcare to $30 from $35, while maintaining an Overweight rating on the shares following the company’s Q3 2025 results and updated guidance.
In its Q3 earnings report, Acadia Healthcare reported a 4.4% increase in revenue for the quarter, reaching $851.6 million. This growth was attributed to various initiatives, including a 3% increase in same facility admissions driven by targeted improvements in acute care referral sources. The company also surpassed earnings estimates, earning $0.72 per share, beating estimates by $0.06.
However, despite the positive revenue growth, Acadia Healthcare’s adjusted EBITDA for Q3 declined to $173 million from $194.3 million in the previous year. This decrease was primarily due to softer-than-expected volumes in the Medicaid business and increased payer friction. As a result, the company revised its Adjusted EBITDA guidance for 2025 to a range of $650 to $660 million, down from the initial guidance of $675 to $700 million.
Acadia Healthcare Company Inc. operates in the behavioral healthcare services sector in the US and Puerto Rico. While the company shows promise as an investment opportunity, there are other AI stocks that may offer greater upside potential with less downside risk. Investors looking for undervalued AI stocks that could benefit from current market trends should explore the best short-term AI stock options.
For more investment opportunities, readers can check out the “30 Stocks That Should Double in 3 Years” and “11 Hidden AI Stocks to Buy Right Now” articles. It’s important to note that the information provided in this article is for informational purposes only and does not constitute financial advice.
